Abstract:Qiongrong Huang, 1, 2 Xiuli Zhang, 2 Zhiyuan Hu 1– 4 1 Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350108, Fujian Province, People's Republic of China; 2 CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, People's Republic of China; 3 School of Nanoscience and Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China; 4 School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, 430205, People's Republic of China Correspondence: Zhiyuan Hu Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350108, Fujian Province, People's Republic of China Tel/Fax +86 10 6265 2116 Email Xiuli Zhang National Center for Nanoscience and Technology (NCNST),No.11 ZhongGuanCun BeiYiTiao, Beijing, 100190, People's Republic of China Tel +010 8254 5752 Email Purpose: Inflammatory bowel disease (IBD) is difficult to diagnose and classify. The purpose of this study is to establish an artificial intelligence model based on fecal multi-omics data for multi-classification diagnosis of IBD and its subtypes. Materials and Methods: A total of 299 clinical cohort studies were included in this study, including 86 healthy people, 140 CD patients and 73 UC patients. Based on the idea of hierarchical modeling for different groups, we model the total population and the groups with self-evaluation of "very well" and "slightly below par", respectively. The original total features were fecal multi-omics data, including metagenomics, metatranscriptomics, proteomics, metabolomics, viromics, faecal calprotectin. The importance, collinearity and other feature engineering methods were used to evaluate the features. Finally, three individualized diagnosis models with less features and high accuracy were obtained. Results: First, we screened 111 features to form the optimal feature set for the total population and established a three-classification individual diagnosis model with AUC of 0.83, which can simultaneously diagnose health, CD and UC. Secondly, according to the hierarchical modeling of the total population, we established two models for population with different self-evaluation. For "very well" population, we screened 59 features and established a three-classification diagnostic model with AUC of 0.85. For the self-evaluation population with "slightly below par", we finally included 22 features and established a three-classification diagnostic model with AUC of 0.84. Only metabolomics and metatranscriptomics features were included in the optimal feature sets. Conclusion: This study provides a valuable method for high accuracy, noninvasive diagnosis and subtype identification of IBD patients. Researchers can choose biomarkers in different models according to different self-evaluation of patients. Simple noninvasive fecal sampling can be used to detect metabolomics and metatranscriptomics data, thus replacing the tedious and painful clinical colonoscopy and biopsy procedures. Keywords: inflammatory bowel diseases, artificial intelligence, multi-omics, noninvasive, precision medicine Inflammatory bowel disease (IBD) is a chronic and incurable disease with a high incidence rate, which seriously affects patients' health and life span. 1 , 2 IBD mainly includes Crohn's disease (CD) and ulcerative colitis (UC). 3 Intestinal tract is the largest immune organ in human body. The imbalance of host intestinal microenvironment is closely related to a variety of intestinal diseases. 4 Therefore, the accurate diagnosis of IBD and its subtypes and other intestinal diseases is very important. At present, the clinical diagnosis of IBD and its subtypes are mostly invasive methods such as colonoscopy and pathological examination. 5 Mossotto et al reported their support vector machine (SVM) model, which distinguishes CD and UC with an accuracy of 0.833 in test data set (48 people), using only eight histological and endoscopic features. 6 In a study of identifying the severity of IBD, they use convolutional neural network model to distinguish mayo 0 vs mayo 1–3 with an AUC of 0.86 in 3981 pictures of 114 -Abstract Truncated-

Establishing a Novel Inflammatory Bowel Disease Prediction Model Based on Gene Markers Identified from Single Nucleotide Variants of the Intestinal Microbiota

Revisiting An Expression Dataset Of Discordant Inflammatory Bowel Disease Twin Pairs Using A Mutation Burden Test Reveals Cyp2c18 As A Novel Marker

Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.

736 - Microbiota Metabolites Short-Chain Fatty Acids Inhibit TH1 Cell Induction of Colitis Through Promoting IL-10 Production Via GPR43

Machine Learning Prediction Model for Inflammatory Bowel Disease Based on Laboratory Markers. Working Model in a Discovery Cohort Study

Intestinal flora and inflammatory bowel disease: Causal relationships and predictive models

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

Gut Microbiota Offers Universal Biomarkers Across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction

Development and Validation of Diagnosis Model for Inflammatory Bowel Diseases Based on a Serologic Biomarker Panel: A Decision Tree Model Study

Microbial genes outperform species and SNVs as diagnostic markers for Crohn's disease on multicohort fecal metagenomes empowered by artificial intelligence

The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-Ptnp] for the Diagnosis of Crohn’s Disease

Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers

Development of a 32-Gene Signature Using Machine Learning for Accurate Prediction of Inflammatory Bowel Disease

Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease.

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

P380 Integrated fecal metagenome and serum metabolome analysis revealed gut microbiome associated serum metabolites as diagnostic biomarkers for inflammatory bowel disease

Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in Crohn's disease by integrating bioinformatics and machine learning

Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease

Identification of key biomarkers for predicting CAD progression in inflammatory bowel disease via machine‐learning and bioinformatics strategies

Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease

A multiple-dimension model for microbiota of patients with colorectal cancer from normal participants and other intestinal disorders